WOCKPHARMA2021-10-012021-12-31in-bse-fin:OneOperatingExpenses01Member WOCKPHARMA2021-10-012021-12-31in-bse-fin:OneOperatingExpenses02Member WOCKPHARMA2021-10-012021-12-31in-bse-fin:FourOperatingExpenses01Member WOCKPHARMA2021-10-012021-12-31in-bse-fin:FourOperatingExpenses02Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares WOCKPHARMA 2021-04-01 2022-03-31 2022-01-20 INR Crores Third quarter Single segment Pharmaceuticals 2021-10-01 2021-12-31 Unaudited Standalone 3086100000.00 30100000.00 3116200000.00 785500000.00 456600000.00 -34600000.00 764000000.00 792200000.00 428600000.00 963800000.00 4156100000.00 -1039900000.00 0.00 -1039900000.00 0.00 -368700000.00 -368700000.00 0.00 -671200000.00 0.00 0.00 0.00 0.00 -671200000.00 -800000.00 -672000000.00 0.00 0.00 554100000.00 5 -6.06 -6.06 0.00 0.00 -6.06 -6.06 1. For Notes to Standalone Results please refer the Notes from the Statement of Standalone Unaudited Results for the quarter and nine months ended 31st December, 2021 as attached which is submitted under Outcome of Board Meeting today. 2. EPS for the quarter and nine months ended 31st December, 2021 is not annualised. Single segment 2021-04-01 2021-12-31 Unaudited Standalone 8980000000.00 103500000.00 9083500000.00 2239200000.00 1547400000.00 -94200000.00 2111900000.00 1946400000.00 1284900000.00 2758400000.00 11794000000.00 -2710500000.00 0.00 -2710500000.00 0.00 -915400000.00 -915400000.00 0.00 -1795100000.00 0.00 0.00 0.00 0.00 -1795100000.00 -2200000.00 -1797300000.00 0.00 0.00 554100000.00 5 -16.20 -16.20 0.00 0.00 -16.20 -16.20 Exchange fluctuation loss / (gain), net 38600000.00 Other expenses 925200000.00 Exchange fluctuation loss / (gain), net 10700000.00 Other expenses 2747700000.00